Evidence map›Paper›PMID 42771098›Full record

ArticleVisual computing for industry, biomedicine, and art2026

ProtoSurv: prototype-guided adaptation of computed tomography foundation model for lung-cancer prognosis prediction.

Chengcai Liu, Shitian Li, Haolin Sang, Xingyu Huang, Chenghao Wang, Yifei Shu, Yi Wu, Jie Tian, Huimao Zhang, Lei Zhang and 1 more

Abstract read
In one paragraph

Article in Visual computing for industry, biomedicine, and art, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chengcai Liu *Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Shitian Li *Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Haolin Sang *Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Xingyu HuangBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Chenghao WangBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Yifei ShuBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Yi WuBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Jie TianBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Huimao ZhangDepartment of Radiology, First Affiliated Hospital of Jilin University, Changchun, Sichuang, 130021, China.
Lei ZhangDepartment of Radiology, First Affiliated Hospital of Jilin University, Changchun, Sichuang, 130021, China. zlei99@jlu.edu.cn.
Shuo WangBeijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China. shuo_wang@buaa.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prognosis prediction is important for precision treatment in lung cancer. Chest computed tomography (CT) and deep learning are feasible approaches for learning imaging-based prognostic representations. However, prognostic labels are difficult to obtain because survival endpoints require long-term follow-up; thus, labeled data for supervised training is limited, increasing the risk of overfitting. Vision-language pretraining offers an approach to mitigate this problem by leveraging large-scale unlabeled CT data; however, most existing methods are not specifically designed to learn prognosis-related features. We propose ProtoSurv, a prototype-guided learning framework for adapting large-scale pretrained CT representations for lung-cancer prognosis prediction under limited supervision. ProtoSurv first pretrains a CT-report vision-language model using 409,261 chest CT sequences from 104,783 patients. It then uses limited labeled prognosis data to construct class prototypes in the pretrained feature space. These prototypes guide pseudolabel assignment, confidence-based filtering, and feature calibration, allowing the selection and refinement of task-relevant unlabeled samples before downstream prognosis modeling. We evaluated ProtoSurv based on two lung-cancer prognosis tasks: progression-free survival prediction in 507 patients receiving targeted therapy and overall survival prediction in 420 patients receiving (chemo-)radiotherapy. ProtoSurv achieved area under the curve/concordance index values of 0.765/0.684 and 0.822/0.727 for the first and second datasets, respectively, outperforming the conventional clinical models and representative deep learning baselines. These results suggest that the prototype-guided adaptation can improve the use of large-scale unlabeled CT data for prognosis modeling when labeled survival data are limited.

Indexed as

Computed tomographyLung cancerPrognosisPrototypeVision-language model

Identifiers

PMID42771098
PMCPMC13598028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.